نتایج جستجو برای: 18f fluorodeoxyglucose petct

تعداد نتایج: 18918  

Introduction: Papillary thyroid carcinoma (PTC) constitutes 75–85% of all thyroid cancers. PTC usually presents as a subtle, commonly slow-growing, painless thyroid mass or a solitary nodule in the neck. This presentation of a cystic neck lump, without the presence of a thyroid nodule, may imitate the course of a benign disease, thus delaying diagnosis and proper treatment.  Case Report: Thr...

Journal: :Hypertension 2012
Paula-Anahi Arias-Loza Michael C Kreissl Susanne Kneitz Franz R Kaiser Ina Israel Kai Hu Stefan Frantz Barbara Bayer Karl-Heinz Fritzemeier Kenneth S Korach Theo Pelzer

Estrogens attenuate cardiac hypertrophy and increase cardiac contractility via their cognate estrogen receptors (ERs) ERα and ERβ. Because female sex hormones enhance global glucose use and because myocardial function and mass are tightly linked to cardiac glucose metabolism, we tested the hypothesis that expression and activation of the ERα might be required and sufficient to maintain physiolo...

2017
Zdenek Rehak Andrea Sprlakova-Pukova Zbynek Bortlicek Zdenek Fojtik Tomas Kazda Marek Joukal Renata Koukalova Jiri Vasina Jana Eremiasova Petr Nemec

BACKGROUND The role of 18F-fluorodeoxyglucose positron emission computed tomography (18F-FDG PET/CT) is increasing in the diagnosis of polymyalgia rheumatica (PMR), one of the most common inflammatory rheumatic diseases. In addition to other locations, increased 18F-FDG accumulation has been detected in the praepubic region in some patients. However, a deeper description and pathophysiological ...

Journal: :Cumhuriyet medical journal 2023

Objective: The new type of Coronavirus (SARS-CoV-2) damages cells by using the angiotensin converting enzyme-2 (ACE2) as a receptor to adhere and go through cell membrane. It is known that some endocrine organs express ACE2 these are potential targets for 2019 disease (Covid-19). This study aimed investigate effect coronavirus (Covid-19) on Fluorine-18 fluorodeoxyglucose (18F-FDG) uptake system...

Journal: :Molecular cancer therapeutics 2008
Elaine T Lam Cindy L O'Bryant Michele Basche Daniel L Gustafson Natalie Serkova Anna Baron Scott N Holden Janet Dancey S Gail Eckhardt Lia Gore

This phase I study was designed to determine the maximum tolerated dose (MTD) and toxicity profile of the combination of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. Patients were treated with escalating doses of gefitinib once daily, capecitabine twice daily (14 of 28 days), and celecoxib twice daily. Plasma samples for biomarkers were obtained at baseline and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید